Glucagon Function: A Descriptive Summary of Its Role in Blood Sugar Regulation
Glucagon Function: A Descriptive Summary of Its Role in Blood Sugar Regulation Glucagon, a 29-amino acid peptide hormone secreted by pancreatic alpha cells, functions primarily to counteract hypoglycemia by stimulating hepatic glycogenolysis and gluconeogenesis. According to clinical data (e.g., Diabetes Care , 2023), glucagon raises blood glucose by 30–50 mg/dL within 10 minutes. In the multi-peptide market, glucagon analogs (e.g., dasiglucagon) offer enhanced stability (shelf-life >24 months at 25°C) versus native glucagon (12 months at 2–8°C). Leading brands (e.g., Novo Nordisk’s GlucaGen, Xeris’s Gvoke) differ in delivery: prefilled auto-injectors reduce dosing errors by 40% (FDA data). Key technical advantages include rapid onset (5–15 min) and high specificity; disadvantages include short half-life ( 6 min) and risk of nausea (10–15% incidence). For product selection, verify GMP certification (e.g., EU GMP, US cGMP) and purity >98% via HPLC. Logistics require cold chain (2–8°C) for liquid formulations; lyophilized powders tolerate ambient conditions for 18 months. Current industry trends show a 12.5% CAGR (2023–2030) driven by dual-action GLP-1/glucagon agonists for obesity.